Qing-Hua Chen1, Xin-Yan Wang1, Jun-Fang Xian1, and Lizhi Xie2
1Department of Radiology, Beijing Tongren Hospital, Capital Medical University, Beijing, China, 2GE Healthcare, China, Beijing, China
Synopsis
This work
assessed the feasibility of quantitative parameters derived from quantitative dynamic
contrast enhancement MR imaging (DCE-MRI) parameters in the prediction and
evaluation of the response to chemotherapy in patients with malignant sinonasal
tumors.
Purpose
Quantitative
Dynamic contrast enhanced MRI (DCE-MRI) parameters derived from pharmacokinetic
modeling provided an effective method of evaluation of blood flow and
microcirculation. The aim of the study to investigate the value of quantitative
dynamic contrast enhancement MR imaging (DCE-MRI) parameters in the prediction
and evaluation of the response to chemotherapy in patients with malignant
sinonasal tumors by comparing the parameter values on the 7th, 21st and 42nd
days after chemotherapy. Methods
This study was
obtained the situational Ethics Committee Approval and informed
consent was waived. DCE-MRI using a 3.0T MR scanner (GE Signa HDxt
scanner with an 8-channel phased array head coil) was taken in 14 (Table.1)
patients with malignant sinonasal tumors before chemotherapy, in which DCE-MRI
was performed in 8 patients on the 7th, 21st and 42nd days after chemotherapy. The
region-of-interest (ROI) was selected based on diffusion weighted imaging,
avoiding the area of cystic and necrosis. Using the two-compartmental model, quantitative parameters including Ktrans, kep and ve
were calculated. Two radiologists reviewed these maps and
measured Ktrans, kep
and ve in the tumor tissue. Rank test analysis was used to compare the Ktrans, kep
and ve values of the tumor with malignant sinonasal
tumors between the response group with no response group before chemotherapy. SPSS22.0 statistical software. The
P value less than 0.05 was considered to represent a significant difference. The change rate of these quantitative
parameter values after chemotherapy was also calculated.Results
Response to chemotherapy of the tumor was found in
11 patients with malignant sinonasal tumors, whereas no response to chemotherapy of the tumor was
confirmed in 3 patients. Ktrans and kep
values of the tumor before
chemotherapy in patients with response to
chemotherapy were significantly bigger than those in patients with no response
to chemotherapy (p<0.01). There
was no significant difference in Ve values
between two groups (p>0.01) (Table.2). Compared with Ktrans values of the tumor before chemotherapy, the
change rate of Ktrans values decreased more than 40% on the 7th,
21st and 42nd days after chemotherapy in five patients with treatment response,
whereas the change rate did not decrease significantly in three patients
without treatment response (Table.3, Figure.1).Conclusion
DCE quantitative parameters may be a
promising imaging biomarker of tumor prognosis. The bigger Ktrans and kep values of the tumor before chemotherapy, the
better the treatment response of the tumor to chemotherapy. More patients are
needed to verify that Ktrans and kep values
of the tumor might be potentially useful in the prediction and evaluation of
treatment response to chemotherapy of malignant sinonasal tumors.Acknowledgements
No acknowledgement found.References
[1] Maroun J A, et al. National Cancer
Institute of Canada[J]. Canadian Medical Association Journal, 1947, 56(3):533.
[2] Fangberget A, et al. Neoadjuvant
chemotherapy in breast cancer-response evaluation and prediction of response to
treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging[J].
European Radiology, 2011, 21(6):1188-99.
[3] Chen X, et al. Role of periodically
rotated overlapping parallel lines with enhanced reconstruction
diffusion-weighted imaging in correcting distortion and evaluating head and
neck masses using 3 T MRI.[J]. Clinical Radiology, 2014, 69(4):403–409.